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Summary
Background: Cardiovascular disease is the most frequent cause of death and disabil-
ity for diabetic patients, and patients with diabetes are more likely to have silent
ischemia. Multi-detector computed tomography (MDCT) allows non-invasive assess-
ment of coronary artery stenosis and plaque properties. In this study, we investigated
whether 64-slice MDCT can non-invasively identify signiﬁcant coronary artery steno-
sis in asymptomatic, type 2 diabetes mellitus (T2DM) and impaired glucose tolerance
(IGT) patients.
Methods and results: The study population consisted of 154 consecutive
asymptomatic patients [IGT (n = 93), T2DM (n = 61)]. All patients underwent contrast-
enhanced 64-slice MDCT. The number of diseased coronary segments was classiﬁed as
showing obstructive (≥50% luminal narrowing) disease or not. Signiﬁcant coronary
stenosis was detected in 43 (27.9%) of 154 enrolled patients. Patients with T2DM
showed signiﬁcantly more coronary stenosis than patients with IGT (41% vs. 19.4%;
p < 0.01). Twenty-three patients [14.9%; IGT (n = 9), T2DM (n = 14)] underwent percu-
taneous coronary intervention (PCI) for severe stenosis. Patients with T2DM showed
signiﬁcantly more calciﬁed plaque than IGT (47.5% vs. 29%; p < 0.05), but not signif-
icantly more soft plaque (19.7% vs. 15.1%; ns), or signiﬁcantly different remodeling
index (1.05± 0.18 vs. 1.04± 0.21; ns), respectively.
∗ Corresponding author. Tel.: +81 6 6581 2881; fax: +81 6 6584 1807.
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Conclusions: 64-Slice MDCT
stenosis in asymptomatic, T2
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Introduction
The detection of sub-clinical coronary artery
disease (CAD) before the development of life-
threatening cardiac complications has great poten-
tial clinical relevance. Considerable discussion
and debate are ongoing regarding the value of
non-invasive screening for non-critical coronary
atherosclerosis or silent ischemia secondary to
ﬂow-limiting stenosis in asymptomatic, type 2 dia-
betes patients.
Type 2 diabetes mellitus (T2DM) is becoming
increasingly prevalent and is considered to increase
the risk of heart disease by two to four times.
Accordingly, 50% of deaths among diabetics in
industrialized countries are due to heart disease.
This proportion is declining, but more slowly than
the equivalent for the general population [1]. CAD
progresses relatively rapidly in diabetic patients,
who, particularly in the setting of autonomic neu-
ropathy, have impaired angina recognition and
may often dismiss prior symptoms of myocardial
ischemia [2,3]. Atypical symptoms can also pre-
vent recognition by caregivers and be a cause of
treatment delay [2]. Many diabetics with CAD do
not develop any symptoms at all prior to an acute
myocardial infarction; in fact, 22—39% develop
silent myocardial ischemia [4,5]. Impaired glucose
tolerance (IGT) is also a signiﬁcant risk factor for
CAD and a strong predictor of death from cardiovas-
cular causes. Multi-detector computed tomography
(MDCT) allows non-invasive assessment of coro-
nary artery stenosis [6,7]. Recent advances in
MDCT, especially in 64-slice MDCT, have dramat-
ically improved spatial and temporal resolution.
These advances have brought us not only visu-
alization of the coronary artery lumen, but also
assessment of plaque properties, i.e. hypodense
plaque and plaque remodeling [8,9].
In this study, we investigated whether 64-slice
MDCT can non-invasively identify signiﬁcant coro-
nary artery stenosis in patients with asymptomatic
T2DM and IGT patients.
MethodsPatients
Our patient population was drawn from 154 con-
secutive, asymptomatic diabetic patients who were
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can non-invasively identify signiﬁcant coronary artery
DM and IGT patients.
Cardiology. Published by Elsevier Ireland Ltd. All rights
dmitted to Sassa Medical Clinic from Decem-
er 2005 to September 2007 for the evaluation
f ischemic heart disease by 64-slice MDCT. All
atients had another coronary risk factor of
ither hypertension or dyslipidemia. First, all
atients underwent contrast-enhanced 64-slice
DCT. Thirty-ﬁve patients underwent invasive coro-
ary angiography due to severe coronary stenosis,
hich was deﬁned as a diameter reduction of
75%. Intravascular ultrasound (IVUS) was per-
ormed in all patients. The deﬁnition of DM was
ased on the cut-off point of fasting plasma glucose
FPG) of ≥126mg/dl (7.0mmol/L) or 75 g oral glu-
ose challenge (2-h plasma glucose) of ≥200mg/dl
11.1mmol/L). The deﬁnition of IGT was based on
he cut-off point of FPG of <126mg/dl (7.0mmol/L)
nd 75 g oral glucose challenge (2-h plasma glucose)
as 140—199mg/dl. No patients presented with
ny anginal equivalent symptoms. Patients who
resented with ischemic echocardiographic (ECG)
hanges (n = 5), congestive heart failure (n = 3),
on-adequate MDCT image due to heavily calci-
ed lesions (n = 6), and arrhythmia (n = 4) were
xcluded.
This study complied with the Declaration of
elsinki. The protocol for the study was approved
y the Ethics Committee of Osaka Ekisaikai Hospi-
al. Written informed consent was obtained from
ll participants prior to MDCT.
can protocol of 64-slice MDCT
4-Slice MDCT data were acquired using a SOMATOM
ensation 64 cardiac (Siemens Medical Solutions,
orchheim, Germany). All patients with a heart rate
f >70 bpm received  blocker (50mg oral metopro-
ol) before the CT scan. A bolus of 65ml of contrast
edia (Omnipaque350, Daiichi Pharmaceutical Co.,
td., Tokyo, Japan) was injected intravenously at a
ow rate of 3.5—4.5ml/s, followed by a 30ml saline
njection at the same ﬂow rate.
Scans were obtained with a collimation of
.66mm with dual focus spots per detector row,
table feed of 11.6mm/rotation, a tube cur-
ent of 750—850mA depending on patient body
eight, a tube voltage of 120 kV, and a gantry
otation speed of 330ms. An estimated mean
ffective radiation dose was approximately 13—
0mSv.
6I
6
T
p
r
E
5
q
a
f
O
u
w
t
u
w
t
a
i
p
a
l
u
w
>
i
a
o
l
a
a
5
p
1
I
i
I
u
o
i
a
a
s
w
r
w
(
t
a
g
c
r
S
b
I
l
I
i
I
e
d
m
i
E
s
U
a
I
<
w
S
S
5
a
Q
t
p
p
t
s
R
P
M
a
a
s
c
(
n
h
A
n
t4-Slice MDCT and DM/IGT patients
mage analysis of the coronary arteries by
4-slice MDCT
he analysis of 64-slice MDCT image data was
erformed by a single experienced reader. Image
econstruction was retrospectively gated to the
CG between 55 and 90% of the RR interval (every
% increments). To acquire images of the best
uality, additional reconstructions were performed
t 2% of the RR interval before and after that phase
ollowing detection of minimum motion artifact.
verlapping trans-axial images were reconstructed
sing a medium sharp convolution kernel (B30f)
ith an image matrix of 512× 512 pixels, slice
hickness of 0.75mm, and an increment of 0.3mm
sing an ECG-gated one-segment scan algorithm
ith a resulting temporal resolution of 165ms in
he center of rotation. All main coronary arteries
nd large (>2mm) side branches were evaluated
rrespective of image quality. Maximum intensity
rojections were used to identify coronary lesions,
nd multi-planar reconstructions in two orthogonal
ongitudinal axes across the coronary lumen were
tilized to classify lesions with signiﬁcant stenosis,
hich was deﬁned as a diameter reduction of
50%. Outer vessel area and arterial remodeling
ndex were assessed by cross-sectional images. The
rterial remodeling index was deﬁned as the ratio
f the outer vessel area at the site of maximal
uminal narrowing and the mean of the proximal
nd distal reference sites. Soft plaque was deﬁned
s plaque showing CT attenuation values less than
0Hounsﬁeld units. Calciﬁed plaque was deﬁned as
laque showing CT attenuation values more than
30Hounsﬁeld units [9].
nvasive coronary angiography and IVUS
maging protocol
n 35 patients, coronary angiography was performed
sing a 6F Judkins-type catheter via the femoral
r the radial approach. All patients received an
ntravenous bolus injection of 3000 IU of heparin
nd intracoronary isosorbide dinitrate (2mg) before
ngiography. Coronary angiograms were reviewed
eparately by an independent observer, unfamiliar
ith the 64-slice MDCT ﬁndings.
After completion of diagnostic coronary angiog-
aphy, and before any intervention, all patients
ere evaluated with IVUS. The IVUS catheter
2.9 F Atlantis, 40MHz, Boston Scientiﬁc Corpora-
ion/SCIMED, Maple Grove, MN, USA) was carefully
dvanced distal to the lesion under ﬂuoroscopic
uidance.
The images were digitized and analyzed with
ommercially available software for longitudinal
M
M
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econstructive IVUS image analysis (Netra IVUS,
cImage Inc., Los Altos, CA, USA). While pulling
ack the catheter, a contrast medium suitable for
VUS imaging was manually infused [10], and the
esion was carefully observed.
VUS image analysis and intervention
ndication
VUS images were interpreted by two independent,
xperienced observers unfamiliar with the 64-MDCT
ata. Evaluation of 2D lesion morphology and other
easurements during IVUS was performed accord-
ng to the American College of Cardiology Clinical
xpert Consensus Document on Standards for Acqui-
ition, Measurement and Reporting of Intravascular
ltrasound Studies (IVUS) [11]. The minimum lumen
rea (MLA) of the culprit lesion was also measured.
f the cases were determined to have an IVUS MLA of
4mm2, percutaneous coronary intervention (PCI)
as performed.
tatistical analysis
tatistical analysis was performed using StatView
.0J (Abacus Concept, Inc.). Results are expressed
s mean value± S.D. for continuous variables.
ualitative data are presented as numbers (%). Con-
inuous variables have been compared using the
aired t-test, and categorical data have been com-
ared using the chi-square test with Fisher’s exact
est. A p value < 0.05 was considered statistically
igniﬁcant.
esults
atient characteristics
DCT was performed in all patients without
ny serious complications. Patient characteristics
re summarized in Table 1. Patients with T2DM
howed signiﬁcantly higher serum levels of gly-
ated hemoglobin (HbA1c) than patients with IGT
7.1± 1.1% vs. 5.5± 0.5%; p < 0.01). Of the 35 coro-
ary angiographies, 23 cases were determined to
ave an IVUS MLA <4mm2 and PCI was performed.
ll 23 patients successfully underwent PCI. A higher
umber of T2DM patients underwent PCI compared
o the IGT group [14 (23%) vs. 9 (9.7%); p < 0.05].DCT results
DCT results are summarized in Table 2. Signiﬁ-
ant coronary stenosis was detected in 43 (27.9%) of
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Table 1 Baseline patient characteristics
Overall (n = 154) IGT (n = 93) T2DM (n = 61)
Age (years) 67± 8 68± 8 66± 9
Male gender 77 (50) 43 (46.2) 34 (55.7)
Number of risk factor
Hypertension 118 (76.6) 75 (80.6) 43 (70.5)
Smoking 30 (19.5) 18 (19.4) 12 (19.7)
Dyslipidemia 57 (37) 40 (43) 17 (27.9)
Body mass index (kg/m2) 24.6± 3.8 24.4± 3.7 24.7± 3.9
Performed PCI 23 (14.9) 9 (9.7) 14* (23)
HbA1c (%) 6.1± 1.1 5.5± 0.5 7.1† ± 1.1
Current IGT/DM treatment
SU 53 (34.4) 15 (16.1) 38 (62.3)
GI 53 (34.4) 25 (26.9) 28 (45.9)
BG 16 (10.4) 6 (6.5) 10 (16.4)
PPAR 18 (11.7) 8 (8.6) 10 (16.4)
Insulin 10 (6.5) 0 (0) 10 (16.4)
Known IGT/DM duration (years) 5.9± 4.7 4.2± 3 8.4± 5.6
. IGT
iguan
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OData are n (%), or mean± S.D. *p < 0.05 vs. IGT; †p < 0.01 vs. IGT
SU: sulfonylurea agent; GI: alpha-glucosidase inhibitor; BG: b
gamma agonist.
154 enrolled patients. Patients with T2DM showed
signiﬁcantly more coronary stenosis than patients
with IGT [25 (41%) vs. 18 (19.4%); p < 0.01]. Over-
all, 26 patients had single vessel disease (60.5%)
and 17 patients had multi-vessel disease (39.5%).
Patients with T2DM showed signiﬁcantly more cal-
ciﬁed plaque than patients with IGT [29 (47.5%) vs.
27 (29%); p < 0.05], but no signiﬁcant difference for
soft plaque [12 (19.7%) vs. 14 (15.1%); ns] or remod-
eling index (1.05± 0.18 vs. 1.04± 0.21; ns).
Fig. 1 shows an example of a typical case involv-
ing severe stenosis from an asymptomatic patient.
Characteristics of patients with and without
PCI
In patients with and without PCI, there were no
differences in age, gender, hypertension, smok-
ing, dyslipidemia, body mass index, and serum
t
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Table 2 64-Slice MDCT results
Overall (n = 154)
Signiﬁcant stenosis 43 (27.9)
Single vessel disease 26 (60.5)
Multi-vessel disease 17 (39.5)
Calcium plaque 56 (36.4)
Soft plaque 26 (16.9)
Remodeling index 1.04± 0.17
Data are n (%), or mean± S.D. *p < 0.05 vs. IGT; †p < 0.01 vs. IGT. Ab: impaired glucose tolerance; T2DM: type 2 diabetes mellitus;
ide agent; PPAR: peroxisome proliferator-activated receptor
evel of HbA1c. Furthermore, there were no dif-
erences in the rate of drug treatment including
ulfonylurea. MDCT ﬁndings of both groups are sum-
arized in Table 3. Frequency of calciﬁed lesions in
he PCI group was signiﬁcantly higher than those
f the non-PCI group [13 (56.5%) vs. 43 (32.8%);
< 0.05]. The number of soft plaque lesions in
he PCI group was higher than those of the non-
CI group [8 (34.8%) vs. 18 (13.7%); p < 0.05] and
emodeling index (1.07± 0.16 vs. 1.02± 0.12; p <
.01).
iscussion
ur study emphasizes the effectiveness of selec-
ively using MDCT to identify individuals with CAD
ho may require more intensive therapy with
ither anti-ischemic or plaque-stabilizing medica-
ions and/or coronary revascularization.
IGT (n = 93) T2DM (n = 61)
18 (19.4) 25† (41)
11 (61.1) 15* (60)
7 (38.9) 10 (40)
27 (29) 29* (47.5)
14 (15.1) 12 (19.7)
1.04± 0.21 1.05± 0.18
breviations shown as in Table 1.
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pigure 1 A patient with asymptomatic single vessel d
oronary artery. (a) Volume rendering image. (b) Multi-pla
IVUS) image of the lesion location.
The American Diabetes Association recommends
ardiac testing in symptomatic patients with T2DM
12]. In non-diabetics, exercise ECG is a com-
on non-invasive test for initially detecting CAD.
owever, diabetics are less likely to be able to
t
E
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Table 3 Characteristics of patients with and without PCI
Wit
Age (years) 66±
Male gender 12
Number of risk factor
Hypertension 18
Smoking 4 (1
Dyslipidemia 14
Body mass index (kg/m2) 26.
HbA1c (%) 6.4
Current IGT/DM treatment
SU 9 (3
GI 10
BG 1 (4
PPAR 2 (8
Insulin 3 (1
Known IGT/DM duration (years) 7.4
MDCT calcium; number of lesion 13*
MDCT soft plaque; number of lesion 8* (
MDCT remodeling index 1.0
Data are n (%), or mean± S.D. *p < 0.05 vs. without PCI; †p < 0.01
multi-detector computed tomography.e. Severe stenosis is observed at mid-portion of right
econstructions (MPR) image. (c) Intravascular ultrasound
erform an exercise test and are also more likely
o have silent myocardial ischemia, which exercise
CG detects less accurately than other modalities
13]. Conversely, coronary MDCT has a clear role
n detecting CAD in diabetics, and is now a widely
h PCI (n = 23) Without PCI (n = 131)
8 67± 8
(52.2) 65 (49.6)
(78.3) 100 (76.3)
7.4) 26 (19.8)
(60.9) 43 (32.8)
0± 4.1 24.4± 3.7
± 1.2 6.1± 1.1
9.1) 44 (33.6)
(43.5) 43 (32.8)
.3) 15 (11.5)
.7) 16 (12.2)
3) 7 (5.3)
± 4.5 5.6± 4.7
(56.5) 43 (32.8)
34.8) 18 (13.7)
7± 0.16† 1.02± 0.12
vs. without PCI. Abbreviations shown as in Table 1. MDCT:
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available method for directly assessing coronary
stenosis and coronary plaque, irrespective of symp-
toms [14,7,8,15,16].
It is widely believed that acute coronary syn-
drome is mainly caused by plaque rupture and
secondary thrombus formation. Previous results
from post-mortem studies have suggested that
plaque rupture occurs most frequently at the point
where the ﬁbrous cap is thinnest and most heav-
ily inﬁltrated by macrophage foam cells, a point
that is most often found in the shoulder of eccen-
tric plaques [17]. Our study results indicated soft
plaque was detected in 16.9%, and as this strongly
indicates the likelihood of being unstable plaque,
it is necessary for patients with DM and hyper-
lipidemia to be considered for more aggressive
treatment methods. 64-Slice MDCT is not only able
to determine the level of stenosis, but also evaluate
this type of unstable plaque.
IGT is also a signiﬁcant risk factor for CAD and
a strong predictor of death from cardiovascular
causes. However, the beneﬁts of treating IGT have
only been recently evaluated. In the collaborative
analysis of diagnostic criteria in Europe (DECODE)
study, a project pooling data from over 22,000 indi-
viduals from 10 European population-based studies,
individuals with IGT had a multivariate-adjusted
hazard ratio of 1.34 [95% conﬁdence interval (95%
CI): 1.14—1.57] of death from CAD compared with
those with normal glucose tolerance [18]. As per
the results of our study, nine cases (9.7%) in the IGT
group required PCI, and there was no signiﬁcance
in soft plaque (that could be considered unstable
plaque) or positive remodeling when compared to
the DM group. This suggests the importance of man-
aging IGT patients.
Study limitations
There can be said to be a number of limitations
associated with the present study. The number
of the study population was relatively small. Cal-
cium deposits deeply affected the reading of MDCT
images. We excluded patients with heavily calciﬁed
plaque from the original population, which could
have affected the accuracy of detection of differ-
ent plaque types. MDCT is still associated with an
elevated radiation dose, and the administration of
contrast media is also required. Finally, the pres-
ence of ischemia cannot be detected with MDCT.
2Using IVUS, patients with an MLA < 4.00mm were
considered to be ischemic and PCI was performed.
This is consistent with the report by Nishioka et
al. [19] that coincides well with stress myocardial
scintigraphy.
[S. Sassa et al.
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